LDN PHARMA LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameLDN PHARMA LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 09400979
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of LDN PHARMA LIMITED?

    • Manufacture of basic pharmaceutical products (21100) / Manufacturing
    • Other human health activities (86900) / Human health and social work activities

    Where is LDN PHARMA LIMITED located?

    Registered Office Address
    45 Gresham Street
    EC2V 7BG London
    England
    Undeliverable Registered Office AddressNo

    What are the latest accounts for LDN PHARMA LIMITED?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnJun 30, 2025
    Next Accounts Due OnMar 31, 2026
    Last Accounts
    Last Accounts Made Up ToJun 30, 2024

    What is the status of the latest confirmation statement for LDN PHARMA LIMITED?

    Last Confirmation Statement Made Up ToJul 31, 2026
    Next Confirmation Statement DueAug 14, 2026
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToJul 31, 2025
    OverdueNo

    What are the latest filings for LDN PHARMA LIMITED?

    Filings
    DateDescriptionDocumentType

    Confirmation statement made on Jul 31, 2025 with updates

    9 pagesCS01

    Statement of capital following an allotment of shares on Mar 31, 2025

    • Capital: GBP 11,682.13
    3 pagesSH01

    Statement of capital following an allotment of shares on Mar 21, 2025

    • Capital: GBP 11,671.86
    3 pagesSH01

    Unaudited abridged accounts made up to Jun 30, 2024

    11 pagesAA

    Statement of capital following an allotment of shares on Oct 17, 2024

    • Capital: GBP 11,530.45
    3 pagesSH01

    Statement of capital following an allotment of shares on Sep 19, 2024

    • Capital: GBP 11,472.94
    3 pagesSH01

    Statement of capital following an allotment of shares on Aug 23, 2024

    • Capital: GBP 11,434.47
    3 pagesSH01

    Statement of capital following an allotment of shares on Aug 12, 2024

    • Capital: GBP 11,430.62
    3 pagesSH01

    Confirmation statement made on Jul 31, 2024 with updates

    8 pagesCS01

    Statement of capital following an allotment of shares on Jan 10, 2024

    • Capital: GBP 11,392.14
    3 pagesSH01

    Unaudited abridged accounts made up to Jun 30, 2023

    11 pagesAA

    Statement of capital following an allotment of shares on Aug 29, 2023

    • Capital: GBP 11,353.67
    3 pagesSH01

    Confirmation statement made on Jul 31, 2023 with updates

    8 pagesCS01

    Statement of capital following an allotment of shares on Apr 19, 2023

    • Capital: GBP 11,276.72
    3 pagesSH01

    Unaudited abridged accounts made up to Jun 30, 2022

    12 pagesAA

    Registered office address changed from 25 Moorgate London EC2R 6AY England to 45 Gresham Street London EC2V 7BG on Aug 18, 2022

    1 pagesAD01

    Confirmation statement made on Jul 31, 2022 with updates

    8 pagesCS01

    Statement of capital following an allotment of shares on Jul 27, 2022

    • Capital: GBP 11,221.22
    3 pagesSH01

    Statement of capital following an allotment of shares on Feb 23, 2022

    • Capital: GBP 11,215.07
    3 pagesSH01

    Statement of capital following an allotment of shares on Feb 02, 2022

    • Capital: GBP 11,207.37
    3 pagesSH01

    Statement of capital following an allotment of shares on Jan 07, 2022

    • Capital: GBP 11,191.98
    3 pagesSH01

    Statement of capital following an allotment of shares on Sep 16, 2021

    • Capital: GBP 11,184.28
    3 pagesSH01

    Statement of capital following an allotment of shares on Aug 24, 2021

    • Capital: GBP 11,180.43
    3 pagesSH01

    Statement of capital following an allotment of shares on Aug 23, 2021

    • Capital: GBP 11,176.59
    3 pagesSH01

    Statement of capital following an allotment of shares on Jun 30, 2021

    • Capital: GBP 11,172.75
    3 pagesSH01

    Who are the officers of LDN PHARMA LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    BURTON, Graham Henry
    Indian River Drive
    32963 Vero Beach
    4005
    Florida
    Usa
    Director
    Indian River Drive
    32963 Vero Beach
    4005
    Florida
    Usa
    United StatesAmericanConsultant199416100001
    DALGLEISH, Angus George
    Burdon Lane
    SM2 7PP Cheam
    7
    Surrey
    United Kingdom
    Director
    Burdon Lane
    SM2 7PP Cheam
    7
    Surrey
    United Kingdom
    United KingdomBritishProfessor Of Oncology, London52081310001
    MITCHELL, Michael Dennis, Henry
    3040 Huldenberg
    Schonenberg 29
    Belgium
    Director
    3040 Huldenberg
    Schonenberg 29
    Belgium
    BelgiumBritishCompany Director188691680001
    SWEENEY, Paul Joseph
    Letterkenny
    Co. Donegal
    Dromore
    Ireland
    Director
    Letterkenny
    Co. Donegal
    Dromore
    Ireland
    IrelandIrishConsultant/Advisor239477250001
    THOMPSON, Ian
    Carricklee Road
    BT82 9SE Strabane
    1
    Northern Ireland
    Director
    Carricklee Road
    BT82 9SE Strabane
    1
    Northern Ireland
    Northern IrelandIrishConsultant/Advisor164312130001
    GORDON, Michael Thomas
    Calleva Park
    Aldermaston
    RG7 8NN Reading
    5 Jupiter House
    Berkshire
    United Kingdom
    Director
    Calleva Park
    Aldermaston
    RG7 8NN Reading
    5 Jupiter House
    Berkshire
    United Kingdom
    EnglandBritishDirector135479350001
    @UKPLC CLIENT DIRECTOR LTD
    Calleva Park
    Aldermaston
    RG7 8NN Reading
    5 Jupiter House
    Berkshire
    United Kingdom
    Director
    Calleva Park
    Aldermaston
    RG7 8NN Reading
    5 Jupiter House
    Berkshire
    United Kingdom
    Identification TypeEuropean Economic Area
    Registration Number04354076
    86283500001

    Who are the persons with significant control of LDN PHARMA LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Mr Paul Joseph Sweeney
    Gresham Street
    EC2V 7BG London
    45
    England
    Apr 06, 2016
    Gresham Street
    EC2V 7BG London
    45
    England
    No
    Nationality: Irish
    Country of Residence: Ireland
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    Mr Ian Thompson
    Carricklee Road
    BT82 9SE Strabane
    1
    Tyrone
    Northern Ireland
    Apr 06, 2016
    Carricklee Road
    BT82 9SE Strabane
    1
    Tyrone
    Northern Ireland
    No
    Nationality: Irish
    Country of Residence: United Kingdom
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0